Search

Your search keyword '"Chang, Joe Y."' showing total 32 results

Search Constraints

Start Over You searched for: Author "Chang, Joe Y." Remove constraint Author: "Chang, Joe Y." Topic lung cancer treatment Remove constraint Topic: lung cancer treatment
32 results on '"Chang, Joe Y."'

Search Results

1. Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.

2. Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics.

Catalog

Books, media, physical & digital resources

3. Clinical Implementation of Intensity Modulated Proton Therapy for Thoracic Malignancies.

4. Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a “No Fly Zone”.

5. On the interplay effects with proton scanning beams in stage III lung cancer.

6. The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy.

7. Toxicity and Patterns of Failure of Adaptive/Ablative Proton Therapy for Early-Stage, Medically Inoperable Non–Small Cell Lung Cancer

8. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer.

9. Cine Computed Tomography Without Respiratory Surrogate in Planning Stereotactic Radiotherapy for Non–Small-Cell Lung Cancer

10. Intrathoracic Patterns of Failure for Non–Small-Cell Lung Cancer With Positron-Emission Tomography/Computed Tomography–Defined Target Delineation

12. Automated Volumetric Modulated Arc Therapy Treatment Planning for Stage III Lung Cancer: How Does It Compare With Intensity-Modulated Radio Therapy?

13. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

14. Cardiac 18F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.

15. Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer.

16. Implementation of Feedback-Guided Voluntary Breath-Hold Gating for Cone Beam CT-Based Stereotactic Body Radiotherapy

17. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.

18. Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes.

19. Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications.

20. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

21. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities.

22. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

23. Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer.

24. Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy

25. Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer

26. Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer

27. Proton Stereotactic Body Radiation Therapy for Clinically Challenging Cases of Centrally and Superiorly Located Stage I Non-Small-Cell Lung Cancer

28. Daily Alignment Results of In-Room Computed Tomography–Guided Stereotactic Body Radiation Therapy for Lung Cancer

29. Stereotactic Body Radiation Therapy for Patients With Lung Cancer Previously Treated With Thoracic Radiation

30. Intensity-Modulated Proton Therapy Reduces the Dose to Normal Tissue Compared With Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small-Cell Lung Cancer: A Virtual Clinical Study

31. Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer

32. Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer